UK - Standard Life Investments (SLI) has appointed Colin Buchan as its third non-executive director.
Buchan, former head of global equities at UBS Warburg, will join SLI as a director, subject to approval from the FSA. Sandy Crombie, chief executive of SLI, said: “We are extremely fortunate to have attracted someone of the calibre of Colin Buchan. Colin’s huge experience of markets around the world will help us greatly in our global development.”
SLI’s other non-executive directors are Hugh Stevenson, the former Mercury Asset Management chairman, and John Hylands.
Buchan’s addition to the board is the latest change to the Scottish firm’s management. Recently, William Littleboy was appointed as operations director, whilst Crombie saw the SLI chairmanship added to his duties.
Last week, SLI announced the appointment of four new additions to its fixed income and equities teams. Jonathan Gibbs, formerly divisional director at Henderson AMP, took over the management of a £2bn index-linked portfolio. Gibbs’ brief will also include the management of institutional fixed income funds.
Gregor MacIntosh joins SLI from local rivals Edinburgh Fund Managers, where he was deputy chief of the bonds team. He will be responsible for euro denominated assets, specifically euro government bonds.
Former Standard & Poor’s director Craig MacDonald joins the firm’s credit team, whilst Perpetual fund manager Mark Niznik joins the UK smaller companies team as an investment director.
By Geoffrey Ho
PTL has appointed Karein Davie as a client director in its Birmingham office.
The level of interest rate hedging increased to £29.5bn of liabilities in the second quarter as pension funds continued to de-risk, according to BMO Global Asset Management's research.
UK inflation has risen for the first time since November to 2.5% in July, up from 2.4% in June, thanks to rising fuel costs and the price of computer games.
The number of DB pension scheme trustees targeting a buyout with an insurer has increased significantly in the past five years, latest research from Willis Towers Watson shows.